N euroectodermal-derived neural crest cells give rise to peripheral and autonomic nervous systems, melanocytes, leptomeninges, and the chromaffin cells of the adrenal medulla, among numerous other vital structures. The term neurocristopathy has been coined to delineate a variety of disorders resulting from specific errors in the development of neural crest progeny, and is further divided into the classifications simple and complex.
N euroectodermal-derived neural crest cells give rise to peripheral and autonomic nervous systems, melanocytes, leptomeninges, and the chromaffin cells of the adrenal medulla, among numerous other vital structures. The term neurocristopathy has been coined to delineate a variety of disorders resulting from specific errors in the development of neural crest progeny, and is further divided into the classifications simple and complex. 2 A simple neurocristopathy is characterized by a single localized aberration such as a solitary neuroblastoma, carcinoid tumor, pheochromocytoma, peripheral neuroectodermal tumor, or thyroid medullary carcinoma. Alternatively, a complex neurocristopathy is denoted by a varied assortment of simple neurocristopathies in a single patient. Represented within the complex category most frequently are the syndromes of neurofibromatosis Types 1 and 2, with their differing diagnostic criteria including combinations of gliomas, meningiomas, malignant melanomas, neurofibromas, pheochromocytomas, and schwannomas. Many other potential complex neurocristopathies do not correspond to named syndromes and may not garner substantial clinical suspicion. However, clinicians should pay careful attention to the possibility of additional benign and malignant neural crest-derived tumors in this population as well. We report a novel complex neurocristopathy in the form of a spinal melanoma in association with a schwannoma, and differentiate this case from 2 prior reports of complex neurocristopathies in the form of ophthalmic melanomas, rather than spinal, in association with other neural crest-derived tumors.
case report

Presentation and Examination
A 46-year-old man initially presented to a referring facility with low-back pain and radiculopathy, at which time neuroimaging revealed 2 thoracolumbar lesions. The patient delayed treatment for 1 year when he subsequently presented to Oregon Health & Science University neurological surgery with 1 month of worsening right lowerextremity numbness, left lower-extremity paresthesias, perineal burning sensation, and several weeks of urinary retention, requiring bladder catheterization. His medical history was significant for hypercholesterolemia, and he reported smoking cessation in 2009 with a cumulative 20 pack-year history. The patient's personal and family histo- Magnetic resonance imaging demonstrated a large intradural extramedullary hemorrhagic lesion at T-12, causing compression of the conus medullaris and a smaller intradural mass at L-5 ( Fig. 1 ).
First Operation
The patient underwent a T11-L1 laminectomy with a subsequent uncomplicated perioperative course. Intraoperatively, the lesion was noted to be hemorrhagic and highly vascularized, requiring vascular clips to control large perimedullary feeding arterioles. The mass emanated from the dura, which was superficially dissected from the pia of the conus using sharp dissection. The mass was resected from the right T-12 nerve root en bloc with the dura, which was primarily repaired using Prolene and TISSEEL. An intraoperative pathological frozen section was reported as an arteriovenous malformation; therefore, no postoperative MR images were obtained. To evaluate for potential arteriovenous malformation, a spinal angiogram was obtained, which demonstrated no evidence of residual vascular lesion. However, final surgical pathology revealed primary CNS melanoma (Fig. 2 ).
Second Operation
The patient was admitted 2 months later for elective resection of the L-5 nerve root lesion via L4-5 laminectomy (Fig. 3 ). This proceeded without complication, and the resultant pathology was consistent with schwannoma WHO Grade I ( Fig. 4A and B) . Notably, there was a melanotic appearance of the arachnoid at the level of the L4-5 schwannoma ( Fig. 4C and D) , with biopsy of the suspicious area showing melanocytosis or benign melanocytoma but no overt melanoma. After an interdisciplinary neurooncology conference review, it was recommended that the patient undergo adjuvant radiotherapy to the residual melanoma resection area at T-12; he declined. He recovered his strength and urinary continence and was without sensory deficits.
Postoperative Course
Ten months after the initial operation, the patient presented with persistent right leg numbness and "shock-like" sensations with coughing but was functionally intact. Repeat MR imaging demonstrated a remaining right T12-L1 lateral recess mass. Serial PET/CT demonstrated a standard uptake value increase of 25% in the right T-12 pedicle over a period of 4 months, signifying active tumor with no evidence of distant metastatic disease (Fig. 5) . Resection of the recurrent melanoma was completed by T-12 costotransversectomy and T10-L3 posterior instrumented fusion. The mass was noted to be completely extradural and was resected en bloc. The patient was again counseled regarding adjuvant radiotherapy and subsequently agreed to undergo therapy. The planning target volume was treated postoperatively with 30 Gy over 5 fractions. At followup 1 year after radiotherapy, the patient was stable with no serious symptoms but occasional back pain. Imaging at that time demonstrated persistent nodular enhancing foci along the dorsal surface of the spinal cord at T-11, T-12, and L-2 with the largest nodule at L-2 measuring 3 mm.
Histopathology and Molecular Examination
The resection at T-12 demonstrated primary CNS malignant melanoma upon histopathological examination. Unbleached H & E sections revealed heavily pigmented neoplasm composed of solid sheets of epithelioid-looking neoplastic melanocytes with large cherry-red nucleoli and ample cytoplasm that was partly filled with pigment. Masson-Fontana special stain confirmed the identity of the pigment as melanin, and melanocytic markers including S100, HMB-45 and Melan-A were also strongly positive. Epithelial membrane antigen and CAM 5.2 were negative. Mitotic figures were not obvious on routine staining, but phosphohistone H3 immunostaining showed about 5 mitotic figures per 10 hpf. Ki 67 proliferative index was also increased (up to 5%-20%). The diagnosis of a lower-grade primary CNS melanocytic neoplasm such as melanocytoma or an intermediate-grade melanocytic neoplasm was considered initially, but lack of nesting pattern, prevalence of epithelioid neoplastic melanocytes, prominent nuclear atypia, and increased mitotic rates were supportive of the diagnosis of melanoma. 6 The specimen obtained from the local recurrence of the tumor showed the same histomorphology. Lack of clinical evidence of melanoma or its metastases elsewhere together with comparatively less significant increase of Ki 67 and quantity of mitotic figures that would be seen in melanoma metastases (17%-38% and 7-35 mitotic figure/10 hpf, respectively) dismissed the diagnosis of secondary melanoma in our case. 3 The L-5 intradural tumor demonstrated typical histomorphology of schwannoma, WHO Grade I with hypercellular and hypocellular areas, and strongly positive S100 immunostaining. The biopsied arachnoid covering at the same level showed heavily pigmented melanocytes. The melanocytes were spindle shaped, demonstrated bland histomorphology, and did not show prominent nucleoli. Mitotic figures were absent and Ki 67 proliferative index was minimal (1%). This lesion was considered either a discrete melanocytoma or a part of diffuse leptomeningeal melanocytosis because of lack of aggressive features. Neurocutaneous melanosis was ruled out clinically.
The main genes driving oncogenesis in melanomas were evaluated using the bidirectional Sanger sequencing technique for possible targeted therapy use. These genes included BRAF, NRAS, c-KIT, GNAQ, and GNA11. Neither of activating mutations of these genes was found in the primary CNS melanoma and the subsequent recurrence. The second melanocytic lesion at L4-5 was also GNAQ and GNA11 negative.
discussion
The first reported case of complex neurocristopathy involved 3 tumors of neural crest origin. 9 A 64-year-old woman with a medical history of diabetes mellitus and systemic hypertension was referred for evaluation of diabetic retinopathy when a left choroidal juxtapapillary malignant melanoma was discovered in association with a right superolateral periorbital neurofibroma and a right sphenoid wing meningioma. An enucleation was performed for the uveal malignant melanoma, which was revealed to be of mixed cell-type, epithelioid cell-rich juxtapapillary malignant melanoma of the choroid. There was no recurrence up to 1 year postoperatively. Interestingly, the patient had no family history of neurofibromatosis, though the association of neurofibromas and meningiomas has long been recognized in this condition. 5 Additionally, neurofibromas and meningiomas have both been reported in association with cutaneous malignant melanomas. 1, 4 The report of Warwar et al. was the first to describe both neurofibroma and meningioma with uveal malignant melanoma in the setting of a complex neurocristopathy.
9
A second report of a complex neurocristopathy involving an ophthalmic melanoma described an 88-year-old woman with no medical history of neurofibromatosis who presented with a choroidal melanoma and ipsilateral optic nerve meningioma. 7 Choroidal malignant melanoma filling the entire globe with secondary angle closure of the left eye was confirmed via ultrasonography. Circumferential proliferation of meningothelial cells with intranuclear inclusion of the optic nerve sheath demonstrated incidental meningioma. The patient died of metastatic disease 6 months postoperatively.
We report the first patient, to our knowledge, who demonstrated complex neurocristopathy involving a spinal melanoma and schwannoma. A review of the existing literature revealed 2 cases of ophthalmic melanoma in association with other neural crest tumors but no additional cases of spinal melanoma in a complex neurocristopathy context. Primary CNS melanoma is a subset of all primary CNS melanotic tumors and has an estimated incidence less than 1% of all melanomas, while schwannomas and meningiomas are more commonly treated spinal pathologies. 8 Upon discovery of a primary CNS malignant melanoma, physicians should be cognizant of other potential tumors of neural crest origin and prepare for the possibility of managing complex neurocristopathy.
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